Holly C. Groom

Holly C. Groom

Auto-generated profile, based on publicly available information

Holly C. Groom

Kaiser Permanente Center for Health Research, Portland, OR, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Journal of Public Health Management & Practice
Verified
Journal Article
Closed access
HGHolly Groom
Holly Groom
DHDavid P. Hopkins
David P. Hopkins
LPLaura J. Pabst
Laura J. Pabst
JMJennifer Murphy Morgan
Jennifer Murphy Morgan
MPMona Patel
Mona Patel
JZJane Zucker
Jane Zucker
Immunizations are the most effective way to reduce incidence of vaccine-preventable diseases. Immunization information systems (IISs) are confidential, population-based, computerized databases that record all vaccination doses administered by participating providers to people residing within a given geopolitical area. They facilitate consolidation of vaccination histories for use by health care providers in determining appropriate client vaccinations. Immunization information systems also provide aggregate data on immunizations for use in monitoring coverage and program operations and to guide public health action. Methods for conducting systematic reviews for the Guide to Community Preventive Services were used to assess the effectiveness of IISs. Reviewed evidence examined changes in vaccination rates in client populations or described expanded IIS capabilities related to improving vaccinations. The literature search identified 108 published articles and 132 conference abstracts describing or evaluating the use of IISs in different assessment categories. Studies described or evaluated IIS capabilities to (1) create or support effective interventions to increase vaccination rates, such as client reminder and recall, provider assessment and feedback, and provider reminders; (2) determine client vaccination status to inform decisions by clinicians, health care systems, and schools; (3) guide public health responses to outbreaks of vaccine-preventable disease; (4) inform assessments of vaccination coverage, missed vaccination opportunities, invalid dose administration, and disparities; and (5) facilitate vaccine management and accountability. Findings from 240 articles and abstracts demonstrate IIS capabilities and actions in increasing vaccination rates with the goal of reducing vaccine-preventable disease.

21 October 2014 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
JLJennifer S. Lin
Jennifer S. Lin
EOElizabeth O'COnnor
Elizabeth O'COnnor
CECorinne V. Evans
Corinne V. Evans
CSCaitlyn A. Senger
Caitlyn A. Senger
MRMaya G. Rowland
Maya G. Rowland
HGHolly C. Groom
Holly C. Groom
Background: Most Americans do not meet diet and physical activity recommendations despite known health benefits. Purpose: To systematically review the benefits and harms of lifestyle counseling interventions in persons with cardiovascular risk factors for the U.S. Preventive Services Task Force. Data Sources: MEDLINE, PsycINFO, the Database of Abstracts of Reviews of Effects, and the Cochrane Central Register of Controlled Trials (January 2001 to October 2013); experts; and existing systematic reviews. Study Selection: Two investigators independently reviewed 7218 abstracts and 553 articles against a set of inclusion and quality criteria. Data Extraction: Data from 74 trials were abstracted by one reviewer and checked by a second. Data Synthesis: At 12 to 24 months, intensive lifestyle counseling in persons selected for risk factors reduced total cholesterol levels by an average of 0.12 mmol/L (95% CI, 0.16 to 0.07 mmol/L) (4.48 mg/dL [CI, 6.36 to 2.59 mg/dL]), low-density lipoprotein cholesterol levels by 0.09 mmol/L (CI, 0.14 to 0.04 mmol/L) (3.43 mg/dL [CI, 5.37 to 1.49 mg/dL]), systolic blood pressure by 2.03 mm Hg (CI, 2.91 to 1.15 mm Hg), diastolic blood pressure by 1.38 mm Hg (CI, 1.92 to 0.83 mm Hg), fasting glucose levels by 0.12 mmol/L (CI, 0.18 to 0.05 mmol/L) (2.08 mg/dL [CI, 3.29 to 0.88 mg/dL]), diabetes incidence by a relative risk of 0.58 (CI, 0.37 to 0.89), and weight outcomes by a standardized mean difference of 0.25 (CI, 0.35 to 0.16). Behavioral changes in dietary intake and physical activity were generally concordant with changes in physiologic outcomes. Limitation: Sparse reporting of patient health outcomes, longer-term follow-up of outcomes, and harms. Conclusion: Intensive diet and physical activity behavioral counseling in persons with risk factors for cardiovascular disease resulted in consistent improvements across various important intermediate health outcomes up to 2 years. Primary Funding Source: Agency for Healthcare Research and Quality.

1 July 2012 in Pediatrics
Verified
Journal Article
Closed access
PDF file
SRSteve G. Robison
Steve G. Robison
HGHolly Groom
Holly Groom
CYCollette Young
Collette Young
OBJECTIVES: Recent studies have described an increase in parental hesitancy regarding vaccines as well as increases in parental adoption of vaccine schedules that delay or limit receipt of recommended vaccines. This study quantifies potential prevalence and trends in alternative schedule compliance by measuring consistent shot-limiting in a metropolitan area of Oregon. METHODS: Retrospective cohort analysis using the Oregon ALERT Immunization Information System to track children born between 2003 and 2009 in the Portland metropolitan area. Joinpoint regression was used to analyze prevalence trends in consistent shot-limiting during that time period. The 2007–2009 Haemophilusinfluenzae type b vaccine shortage and increased availability of combination vaccines were also examined for their effects on shot-limiting rates. RESULTS: A total of 4502 of 97 711 (4.6%) children met the definition of consistent shot-limiters. The proportion of consistent shot-limiters in the population increased from 2.5% to 9.5% between 2006 and 2009. Compared with those with no or episodic limiting, consistent shot-limiters by 9 months of age had fewer injections (6.4 vs 10.4) but more visits when immunizations were administered (4.2 vs 3.3). However, only a small minority of shot-limiters closely adhered to published alternative schedules. CONCLUSIONS: The percentage of children consistently receiving 2 or fewer vaccine injections per visit between birth and age 9 months increased threefold within a 2-year period, suggesting an increase in acceptance of non–Advisory Committee on Immunization Practices vaccine schedules in this geographic area.

1 July 2005
Verified
Journal Article
Closed access
ORO Ronveaux
O Ronveaux
DRD Rickert
D Rickert
SHS Hadler
S Hadler
HGH Groom
H Groom
JLJ Lloyd
J Lloyd
MBM Birmingham
M Birmingham

1 October 2019 in Vaccine
Verified
Journal Article
Closed access
HGHolly C. Groom
Holly C. Groom
NSNing Smith
Ning Smith
SIStephanie A. Irving
Stephanie A. Irving
PKPadma Koppolu
Padma Koppolu
GBGabriela Vazquez- Benitez
Gabriela Vazquez- Benitez
ANAllison L. Naleway
Allison L. Naleway

1 January 2008 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
HGHolly Groom
Holly Groom
EDEric Dieperink
Eric Dieperink
DNDavid B. Nelson
David B. Nelson
JGJudith Garrard
Judith Garrard
JJJames R. Johnson
James R. Johnson
SHSamuel B. Ho
Samuel B. Ho
To determine the outcomes of implementing clinical care guidelines for Hepatitis C screening, evaluation, and treatment in a large urban Veterans Affairs Medical Center. Little information exists regarding the actual outcomes of institutional screening programs for Hepatitis C. Retrospective review of all patients tested for Hepatitis C at the Minneapolis Veterans Affairs Medical Center from January 1, 2000 to December 31, 2001. Logistic regression was used to determine factors related to successful referral and treatment. During this period 36,422 unique patients were screened for Hepatitis C virus (HCV) risk factors, resulting in 12,485 HCV enzyme-linked immunoassay antibody tests. HCV antibodies were positive in 681 (5.4%) patients and 520 (4.2%) were HCV-RNA-positive. Of HCV-RNA-positive patients, 430 (83%) were referred, 382 (73%) attended the Hepatitis clinic, and 232 (44.6%) received liver biopsies. Patients referred had significantly fewer comorbidities, known marital status, and greater prior clinic attendance than those not referred. Overall, 124 patients with established fibrosis received antiviral therapy (32% of patients attending clinic or 24% of viremic cohort). White race, fewer major medical problems, and age less than 60 years predicted antiviral treatment. Sustained virologic response occurred in 46 (37%) of treated patients (9% of the viremic cohort). Patients with a sustained virologic response include 17 patients with stage 3 to 4 fibrosis. This screening and referral program resulted in 73% of HCV-RNA-positive patients attending a specialty Hepatitis C clinic and 24% of those most likely to benefit received antiviral therapy. Measures to increase referral, engagement in care, and antiviral treatment are needed.